Netherlands· NL-e55531c01a1d
Famciclovir Double-e Pharma 125 mg, filmomhulde tabletten
A famciclovir product containing famciclovir, registered in Netherlands by Double-E Pharma Ltd.. The same ATC class is registered in 12 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Famciclovir is registered in 12 of 19 countries.
Countries holding a registration under ATC J05AB09 (famciclovir), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 6 of them publish a price we can compare per daily dose
Famciclovir · ATC J05AB09
12 / 19 countries
- Canada
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of famciclovir costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), the median price runs from $15.01 in Italy to $32.07 in Switzerland — a ×2.1 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Famciclovir · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$32.07
- ES Spain$21.31
- FR France$20.36
- IT Italy$15.01
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- FAMCICLOVIR
- Manufacturer
- Double-E Pharma Ltd.
- Country
- Netherlands (NL)
- ATC code
- J05AB09
- ATC class
- Famciclovir
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id34066
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
118 interactions on record for famciclovir.
Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Famciclovir · interactions on record
118 records
- 5 moderate
- 113 info
Most severe, free to view
- PemetrexedL01BA04moderate
- CladribineL01BB04moderate
- Talimogene laherparepvecL01XL02moderate
- Talimogen laherparepvecL01XX51moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Famciclovir in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesFamciclovirAvKARE
- SpainFAMCICLOVIR NORMON 125 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGLaboratorios Normon S.A.
- FinlandFamvirPhoenix Labs
- SwedenFamvir 125 mg Filmdragerad tablettPhoenix Labs Unlimited Company
- IrelandFamvir 125 mg film-coated tabletsPhoenix Labs
- FranceORAVIR 125 mg, comprimé pelliculéPHOENIX LABS (IRLANDE)
- IcelandFamvirPhoenix Labs Unlimited Company
- United KingdomFamciclovir 125mg tabletsA A H Pharmaceuticals Ltd
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Famvir
- Cyprus · Famvir
- Germany · Famvir
- Denmark · Famciclovir Viatris, Famvir
- Spain · Famciclovir Normon, Famciclovir Pensa
- Finland · Famvir
- France · Oravir
- United Kingdom (Northern Ireland) · Famciclovir Accord Healthcare, Famciclovir Cadila Pharmaceuticals (Europe)
- Greece · Famcilet, Famvir
- Hungary · Famvir
- Ireland · Famciclovir Teva, Famvir
- Iceland · Famvir
- Italy · Coirgen, Famciclovir Mylan Generics
- Malta · Famvir
- Sweden · Famvir
- Slovakia · Famciclovir Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/af6cb561-fe0b-4d38-8f38-66cdd456d1bf GET /v1/drugs/af6cb561-fe0b-4d38-8f38-66cdd456d1bf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h34066_smpc.pdf",
"strength": null,
"atc_label": "Famciclovir",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg34066",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CROSCARMELLOSE NATRIUM (E 468)",
"GLYCEROLTRIACETAAT (E 1518)",
"HYDROXYPROPYLCELLULOSE, LAAG GESUBSTITUEERD (E 463a)",
"HYPROMELLOSE (E 464)",
"MACROGOL",
"NATRIUMSTEARYLFUMARAAT",
"NATRIUMZETMEELGLYCOLAAT",
"POLYDEXTROSE (E 1200)",
"SILICIUMDIOXIDE (E 551)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"FAMCICLOVIR"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h34066.pdf",
"authorised_at": "2008/07/11",
"procedure_number": "NL/H/0868/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "34066",
"additional_monitoring": "N"
}See everything about famciclovir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.